The Asia-Pacific Service Laboratory Market was valued at USD 8,650 million in 2025 and is expected to reach USD 17,420 million by 2035, growing at a CAGR of 6.7% from 2024 to 2035. The market is driven by advances in diagnostic technologies, rising demand for contract laboratory services in pharmaceutical and biotechnology sectors, and growing awareness about quality and regulatory compliance. Countries such as China, Japan, and India are fueling robust growth through increased healthcare spending and industry partnerships.
The economic impact of tariffs on "Asia-Pacific Service Laboratory Market".
Asia-Pacific Service Laboratory Market Growth Drivers
Rising Outsourcing in Pharma & Biotech: Pharmaceutical and biotechnology companies are increasingly outsourcing laboratory services for clinical trials and quality assurance to minimize operational costs and focus on core R&D. In 2023, China-based WuXi AppTec expanded its service lab footprint across Asia-Pacific, reflecting the surge in demand. Outsourcing allows companies to benefit from local expertise and compliant infrastructure, accelerating time to market for new drugs and therapies.
Regulatory Compliance and Quality Standards: The tightening of regulatory standards, including ISO certifications and Good Laboratory Practice (GLP), is compelling organizations to adopt certified service laboratories. SGS, with its strong presence in the region, reported increased client acquisition after expanding accredited services in India and Southeast Asia in early 2024. Such compliance assures accurate results and bolsters trust among end-users, further driving market revenue.
Asia-Pacific Service Laboratory Market Trends
Integration of Digital Technologies: Digital transformation is reshaping service laboratories with Laboratory Information Management Systems (LIMS), automation, and data analytics. In February 2024, Thermo Fisher Scientific announced partnerships with several regional labs in Japan and Singapore to implement cloud-based LIMS, boosting operational efficiency and data security. This digital shift improves turnaround time, enhances data integrity, and supports the scalability of services.
Rise of Specialized Testing Services: There is increasing demand for specialized analytical, genetic, and environmental testing. Eurofins Scientific has expanded its genomics and advanced analytics labs in India and China, catering to pharmaceutical, food safety, and environmental monitoring. The rise of personalized medicine and precision diagnostics is fueling adoption of niche laboratory services, leading to robust growth across emerging economies.
Asia-Pacific Service Laboratory Market Opportunity
Expansion into Emerging Markets: Rapid industrialization and urbanization in Southeast Asia present vast opportunities for laboratory service providers. Emerging economies, like Vietnam and Indonesia, are experiencing increased regulatory scrutiny, driving the need for advanced testing facilities. Companies entering these markets early can capture substantial market share.
Collaborations & Strategic Partnerships: Collaborations between service labs, hospitals, and research institutions are improving accessibility of advanced diagnostic services in remote regions. For example, a partnership between SRL Diagnostics and local healthcare providers in India has enhanced genetic and molecular testing coverage.
Asia-Pacific Service Laboratory Market Revenue (USD Million), 2020-2035
The revenue chart demonstrates consistent growth in the Asia-Pacific Service Laboratory Market from 2020 to 2035. Starting at USD 5,300 million in 2020, the market exhibits a steady rise with minor fluctuations, reaching USD 8,650 million in 2025. By 2030, revenue is projected to hit USD 12,540 million, driven by technology adoption and regulatory changes. The forecast anticipates that by 2035, the market will reach an impressive USD 17,420 million. This growth trajectory highlights the increasing reliance on outsourced laboratory services, digital transformation initiatives, and expanding pharmaceutical R&D activities in the region.
Asia-Pacific Service Laboratory Market by Regions Share (%), 2025
The pie chart for 2025 reveals China’s dominance in the Asia-Pacific Service Laboratory Market, accounting for 38% of market share due to its mature healthcare infrastructure and heavy R&D investment. Japan claims 23%, supported by advanced technology adoption, while India holds 17%, attributed to expanding pharmaceutical manufacturing and regulatory reforms. The ASEAN region (including Singapore, Malaysia, and Indonesia) captures 13% share as a fast-growing hub for clinical and analytical services. Australia and South Korea together account for 9%, driven by high quality standards and investments in biotech sectors. This distribution illustrates how market maturity and regulatory frameworks influence regional shares.
Recent Developments in Asia-Pacific Service Laboratory Market
In April 2024, Eurofins Scientific inaugurated a new advanced genomics laboratory in Shanghai, China, significantly expanding its capacity for next-generation sequencing and pharmaceutical analysis. This facility is poised to cater to rising demand for precision diagnostics and supports local biotech start-ups, aligning with China’s strategic healthcare reforms.
SGS announced in March 2024 the opening of a major environmental testing lab in Jakarta, Indonesia. The new facility uses AI-backed analytical tools for rapid soil and water quality assessments, serving the mining and agriculture industries. This move underlines SGS’s focus on expanding services in rapidly developing Southeast Asian markets.
In February 2024, SRL Diagnostics entered into a partnership with Apollo Hospitals in India to offer advanced molecular and genetic testing services nationwide. This collaboration aims to bridge diagnostic gaps in rural areas, leveraging SRL’s laboratory network and Apollo’s healthcare delivery platforms. The initiative is expected to improve the accessibility and quality of critical healthcare screening services.
Press Releases